138 related articles for article (PubMed ID: 25468035)
1. Synthesis and biological evaluation of pyridinone analogues as novel potent HIV-1 NNRTIs.
Cao Y; Zhang Y; Wu S; Yang Q; Sun X; Zhao J; Pei F; Guo Y; Tian C; Zhang Z; Wang H; Ma L; Liu J; Wang X
Bioorg Med Chem; 2015 Jan; 23(1):149-59. PubMed ID: 25468035
[TBL] [Abstract][Full Text] [Related]
2. Novel pyridinone derivatives as non-nucleoside reverse transcriptase inhibitors (NNRTIs) with high potency against NNRTI-resistant HIV-1 strains.
Li A; Ouyang Y; Wang Z; Cao Y; Liu X; Ran L; Li C; Li L; Zhang L; Qiao K; Xu W; Huang Y; Zhang Z; Tian C; Liu Z; Jiang S; Shao Y; Du Y; Ma L; Wang X; Liu J
J Med Chem; 2013 May; 56(9):3593-608. PubMed ID: 23540737
[TBL] [Abstract][Full Text] [Related]
3. Discovery of novel diarylpyrimidines as potent HIV NNRTIs via a structure-guided core-refining approach.
Li X; Chen W; Tian Y; Liu H; Zhan P; De Clercq E; Pannecouque C; Balzarini J; Liu X
Eur J Med Chem; 2014 Jun; 80():112-21. PubMed ID: 24769349
[TBL] [Abstract][Full Text] [Related]
4. Discovery of 2-pyridone derivatives as potent HIV-1 NNRTIs using molecular hybridization based on crystallographic overlays.
Chen W; Zhan P; Rai D; De Clercq E; Pannecouque C; Balzarini J; Zhou Z; Liu H; Liu X
Bioorg Med Chem; 2014 Mar; 22(6):1863-72. PubMed ID: 24581546
[TBL] [Abstract][Full Text] [Related]
5. Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 2: discovery of novel [1,2,4]Triazolo[1,5-a]pyrimidines using a structure-guided core-refining approach.
Wang L; Tian Y; Chen W; Liu H; Zhan P; Li D; Liu H; De Clercq E; Pannecouque C; Liu X
Eur J Med Chem; 2014 Oct; 85():293-303. PubMed ID: 25089812
[TBL] [Abstract][Full Text] [Related]
6. Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 4: design, synthesis and biological evaluation of novel imidazo[1,2-a]pyrazines.
Huang B; Liang X; Li C; Chen W; Liu T; Li X; Sun Y; Fu L; Liu H; De Clercq E; Pannecouque C; Zhan P; Liu X
Eur J Med Chem; 2015 Mar; 93():330-7. PubMed ID: 25707013
[TBL] [Abstract][Full Text] [Related]
7. Flexible docking of pyridinone derivatives into the non-nucleoside inhibitor binding site of HIV-1 reverse transcriptase.
Medina-Franco JL; Rodríguez-Morales S; Juárez-Gordiano C; Hernández-Campos A; Jiménez-Barbero J; Castillo R
Bioorg Med Chem; 2004 Dec; 12(23):6085-95. PubMed ID: 15519154
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and anti-HIV evaluation of novel diarylnicotinamide derivatives (DANAs) targeting the entrance channel of the NNRTI binding pocket through structure-guided molecular hybridization.
Liu Z; Chen W; Zhan P; De Clercq E; Pannecouque C; Liu X
Eur J Med Chem; 2014 Nov; 87():52-62. PubMed ID: 25240095
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of 3-benzyloxy-linked pyrimidinylphenylamine derivatives as potent HIV-1 NNRTIs.
Rai D; Chen W; Tian Y; Chen X; Zhan P; De Clercq E; Pannecouque C; Balzarini J; Liu X
Bioorg Med Chem; 2013 Dec; 21(23):7398-405. PubMed ID: 24134904
[TBL] [Abstract][Full Text] [Related]
10. Structure-based bioisosterism design, synthesis and biological evaluation of novel 1,2,4-triazin-6-ylthioacetamides as potent HIV-1 NNRTIs.
Zhan P; Li X; Li Z; Chen X; Tian Y; Chen W; Liu X; Pannecouque C; De Clercq E
Bioorg Med Chem Lett; 2012 Dec; 22(23):7155-62. PubMed ID: 23084898
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of N2,N4-disubstituted-1,1,3-trioxo-2H,4H-pyrrolo[1,2-b][1,2,4,6]thiatriazine derivatives as HIV-1 NNRTIs.
Chen W; Zhan P; De Clercq E; Pannecouque C; Balzarini J; Jiang X; Liu X
Bioorg Med Chem; 2013 Nov; 21(22):7091-100. PubMed ID: 24119448
[TBL] [Abstract][Full Text] [Related]
12. Design, Synthesis, and Anti-HIV Evaluation of Novel Triazine Derivatives Targeting the Entrance Channel of the NNRTI Binding Pocket.
Chen X; Meng Q; Qiu L; Zhan P; Liu H; De Clercq E; Pannecouque C; Liu X
Chem Biol Drug Des; 2015 Jul; 86(1):122-8. PubMed ID: 25358434
[TBL] [Abstract][Full Text] [Related]
13. Discovery of nitropyridine derivatives as potent HIV-1 non-nucleoside reverse transcriptase inhibitors via a structure-based core refining approach.
Wang J; Zhan P; Li Z; Liu H; De Clercq E; Pannecouque C; Liu X
Eur J Med Chem; 2014 Apr; 76():531-8. PubMed ID: 24602795
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of novel acetamide-substituted doravirine and its prodrugs as potent HIV-1 NNRTIs.
Wang Z; Yu Z; Kang D; Zhang J; Tian Y; Daelemans D; De Clercq E; Pannecouque C; Zhan P; Liu X
Bioorg Med Chem; 2019 Feb; 27(3):447-456. PubMed ID: 30606670
[TBL] [Abstract][Full Text] [Related]
15. 2,4,5-Trisubstituted thiazole derivatives as HIV-1 NNRTIs effective on both wild-type and mutant HIV-1 reverse transcriptase: Optimization of the substitution of positions 4 and 5.
Xu Z; Guo J; Yang Y; Zhang M; Ba M; Li Z; Cao Y; He R; Yu M; Zhou H; Li X; Huang X; Guo Y; Guo C
Eur J Med Chem; 2016 Nov; 123():309-316. PubMed ID: 27484516
[TBL] [Abstract][Full Text] [Related]
16. 2,4,5-Trisubstituted thiazole derivatives: a novel and potent class of non-nucleoside inhibitors of wild type and mutant HIV-1 reverse transcriptase.
Xu Z; Ba M; Zhou H; Cao Y; Tang C; Yang Y; He R; Liang Y; Zhang X; Li Z; Zhu L; Guo Y; Guo C
Eur J Med Chem; 2014 Oct; 85():27-42. PubMed ID: 25072874
[TBL] [Abstract][Full Text] [Related]
17. Fused heterocyclic compounds bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 1: design, synthesis and biological evaluation of novel 5,7-disubstituted pyrazolo[1,5-a]pyrimidine derivatives.
Tian Y; Du D; Rai D; Wang L; Liu H; Zhan P; De Clercq E; Pannecouque C; Liu X
Bioorg Med Chem; 2014 Apr; 22(7):2052-9. PubMed ID: 24631361
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of pyridazine derivatives as novel HIV-1 NNRTIs.
Li D; Zhan P; Liu H; Pannecouque C; Balzarini J; De Clercq E; Liu X
Bioorg Med Chem; 2013 Apr; 21(7):2128-34. PubMed ID: 23415090
[TBL] [Abstract][Full Text] [Related]
19. Discovery of novel piperidine-substituted indolylarylsulfones as potent HIV NNRTIs via structure-guided scaffold morphing and fragment rearrangement.
Li X; Gao P; Huang B; Zhou Z; Yu Z; Yuan Z; Liu H; Pannecouque C; Daelemans D; De Clercq E; Zhan P; Liu X
Eur J Med Chem; 2017 Jan; 126():190-201. PubMed ID: 27750153
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of DAPY-DPEs hybrids as non-nucleoside inhibitors of HIV-1 reverse transcriptase.
Wu HQ; Yao J; He QQ; Chen WX; Chen FE; Pannecouque C; De Clercq E; Daelemans D
Bioorg Med Chem; 2015 Feb; 23(3):624-31. PubMed ID: 25537532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
